|
|||||
|
|
Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer |
|
| Authors: | Ulka N. Vaishampayan Joseph Fontana Lance K. Heilbrun Daryn Smith Elisabeth Heath Brenda Dickow William D. Figg |
| Affiliation: | 1. Department of Oncology, Department of Medicine, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI;2. Biostatistics Core, Barbara Ann Karmanos Cancer Institute, Detroit, MI;3. Clinical Trials Office, Barbara Ann Karmanos Cancer Institute, Detroit, MI;4. Medical Oncology Branch, National Cancer Institute, Bethesda, MD |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |